Clinical Trial Update: OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on optimizing aldosterone receptor antagonist therapy using Sodium Zirconium Cyclosilicate in heart failure. The study status is A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hyperkalemia

Drugs mentioned

• Sodium Zirconium Cyclosilicate (sodium zirconium cyclosilate)

Snippet

Sponsor: Michael Fu | Conditions: Heart Failure, Hyperkalemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING